Insights+: COVID-19 Healthcare News Monthly Updates – December 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has been named “SARS-CoV-2” (severe acute respiratory syndrome coronavirus and the disease it causes has been named “Coronavirus Disease 2019” (COVID-19). The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019. Life sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this disease. PharmaShots is keeping a track of all of the important updates in the Life-sciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date.

01. NeuroRx and Relief Conclude Enrollment in their Phase 2b/3 Trial of RLF-100 for Critical COVID-19 with Respiratory Failure

Dec 29, 2020 | Clinical Trial

02. Regeneron Announces Encouraging Initial Data from COVID-19 Antibody Cocktail Trial in Hospitalized Patients on Low-flow Oxygen

Dec 29, 2020 | Regulatory

03. Introducing COMIRNATY, the EU Brand Name for Pfizer & BioNTech’s COVID-19 Vaccine, Developed by Brand Institute

Dec 28, 2020 | Regulatory

04. INOVIO Announces Publication of Phase 1 Data from its COVID-19 DNA Vaccine Candidate, INO-4800 in The Lancet’s EClinicalMedicine

Dec 24, 2020 | Collaboration

05. Aurobindo Pharma and COVAXX Sign an Exclusive Agreement to Develop and Commercialize COVID-19 Vaccine UB-612 for India and UNICEF

Dec 24, 2020 | Collaboration

06. Providence Therapeutics COVID-19 Vaccine Receives Health Canada Authorization to Begin Clinical Trials

Dec 23, 2020 | Regulatory

07. Serum Institute Of India And Dynavax Announce First Participants Dosed In The Phase 1/2 Clinical Trial For A COVID-19 Vaccine

Dec 23, 2020 | Clinical Trial

08. Infor and MphRx Announce Global Solution to Help Healthcare Organizations Manage COVID-19 Vaccine Inoculation with Real-World Clinical Data

Dec 22, 2020 | Clinical Trial

09. eTrueNorth Enabling Patient Recruitment in Clinical Trial to Accelerate the Use of Wearable Diagnostics for Early Identification and Containment of COVID-19

Dec 22, 2020 | Clinical Trial

10. RedHill’s Phase 2/3 COVID-19 Study of Opaganib Passes Second DSMB with Unanimous Recommendation to Continue

Dec 22, 2020 | Clinical Trial

11. RDIF, The Gamaleya National Center, AstraZeneca and R-Pharm sign an Agreement to Cooperate on COVID-19 Vaccine Development

Dec 21, 2020 | Collaboration

12. Principle LTC’s Tower Nursing & Rehabilitation Center Joins with Eli Lilly and Company on Phase 3 Drug Trial for COVID-19 Prevention

Dec 21, 2020 | Clinical Trial

13. Positive Results Show that C21 can Become an Important Complement to COVID-19 Vaccines

Dec 21, 2020 | Clinical Trial

14. ImmuneMed’s hzVSF-v13, COVID-19 Clinical Trials Accelerate Development of the Treatment

Dec 20, 2020 | Clinical Trial

15. Data from ACTT-2 Trial of Baricitinib in Hospitalized COVID-19 Patients Supportive of the U. S. FDA EUA Published in New England Journal of Medicine

Dec 19, 2020 | Clinical Trial

16. Lilly to Begin Pragmatic Study of Neutralizing Antibody Bamlanivimab (LY-CoV555) for COVID-19 in New Mexico

Dec 18, 2020 | Clinical Trial

17. Stroke and Altered Mental State Increase Risk of Death for COVID-19 Patients

Dec 18, 2020 | Clinical Trial

18. Beckman Coulter Launches One of the First High-Quality, High-Throughput COVID-19 Antigen Test Ideal for Mass Testing in the U.S.

Dec 18, 2020 | Regulatory

19. Research on Preventative Nasal Spray, Which Protects Against COVID-19 and Common Cold, Published in Leading Peer-Reviewed Academic Journals

Dec 17, 2020 | Clinical Trial

20. New England Journal of Medicine Publishes Positive Initial Regeneron Antibody Cocktail Results in Non-hospitalized Patients with COVID-19

Dec 17, 2020 | Clinical Trial

21. Circuit Clinical And The Center for Integrated Global Biomedical Sciences At The University at Buffalo Join Efforts In Regional And Global COVID-19 Clinical Research

Dec 17, 2020 | Collaboration

22. Pathology Lab and Health Information Exchange Partner with iSpecimen to Bring COVID-19 Specimens to Researchers

Dec 17, 2020 | Collaboration

23. Ampion Demonstrates Safety In COVID-19 Patients And Initiates Global Clinical Trial For Intravenous Ampion

Dec 17, 2020 | Clinical Trial

24. Pressure BioSciences PCT Platform at Forefront in Generating Pivotal Findings by Diverse COVID-19 Research Teams in USA, China, and Europe

Dec 17, 2020 | Regulatory

25. BAT progresses COVID-19 candidate vaccine into Phase I human clinical trials

Dec 16, 2020 | Clinical Trial

26. International, Federal, State and Local Agencies Choose Salesforce to Help Manage their COVID-19 Vaccine Efforts

Dec 16, 2020 | Regulatory

27. Coronavirus (COVID-19) Update: FDA Authorizes Antigen Test as First Over-the-Counter Fully At-Home Diagnostic Test for COVID-19

Dec 15, 2020 | Regulatory

28. RedHill’s Phase 2/3 COVID-19 Candidate Opaganib Reduces ARDS-Related Blood Clotting in Preclinical Model

Dec 15, 2020 | Clinical Trial

29. Muscular Dystrophy Association Releases FAQs for the Neuromuscular Disease Community for Access to the COVID-19 Vaccines

Dec 15, 2020 | Regulatory

30. Medela Announces New Data Demonstrating that Thopaz+ Digital Chest Drain Improves Safety and Helps Prevent Cross-Contamination During the COVID-19 Pandemic and Beyond

Dec 15, 2020 | Clinical Trial

31. Binx Health Receives EUA Authorizing At-Home COVID-19 Sample Collection by Universities and Employers

Dec 15, 2020 | Regulatory

32. Harbour BioMed and Utrecht University Announce License Agreement with AbbVie and Initiation of COVID-19 Antibody Clinical Trials

Dec 14, 2020 | Collaboration

33. Anixa Biosciences Covid-19 Therapy Demonstrates Comparable Potency to Remdesivir in Pre-Clinical Testing

Dec 14, 2020 | Clinical Trial

34. Emmes Announces its Contribution to Second Remdesivir Clinical Trial for COVID-19

Dec 14, 2020 | Clinical Trial

35. HLS Therapeutics Reports Efficacy and Safety Results from Pilot Study Treating COVID-19 Infected Outpatients with Vascepa (Icosapent Ethyl)

Dec 14, 2020 | Clinical Trial

36. Pharmacy Organizations Welcome FDA Authorization of COVID Vaccine: “We Stand Ready to Serve”

Dec 11, 2020 | Regulatory

37. Kintor Proxalutamide’s COVID-19 Clinical Trial Shows Significant Reduction in Hospitalization and Ventilation Rates

Dec 11, 2020 | Clinical Trial

38. Data from ACTT-2 Trial of Baricitinib in Hospitalized COVID-19 Patients Supportive of the EUA Published in New England Journal of Medicine

Dec 11, 2020 | Clinical Trial

39. ADEXUSDx COVID-19 Antibody Test Filed for Point of Care Emergency Use Authorization

Dec 10, 2020 | Regulatory

40. INOVIO and Advaccine Announce First Dosing of Subject in Phase 2 Clinical Trial for COVID-19 DNA Vaccine Candidate INO-4800 in China

Dec 10, 2020 | Clinical Trial

41. The Himalaya Drug Company shares results of a clinical study that evaluated the role of herbal immunomodulators as an adjuvant treatment in the management of COVID-19

Dec 10, 2020 | Clinical Trial

42. Pharming Announces Enrolment of First Patient in US Clinical Trial for the Treatment of COVID-19 with RUCONEST

Dec 10, 2020 | Clinical Trial

43. Cyxone Receives Regulatory Approval to Initiate a Clinical Phase 2 Study with Rabeximod in Covid-19 patients

Dec 08, 2020 | Regulatory

44. NorthShore Joins Fight Against COVID-19 with Convalescent Plasma Trials for Close Contact Exposed and Newly Diagnosed Patients

Dec 08, 2020 | Clinical Trial

45. Vicore Pharma Reports Positive Top Line Data from the ATTRACT Clinical Study in Patients with COVID-19

Dec 08, 2020 | Clinical Trial

46. Eurofins U.S. Clinical Diagnostic Laboratories Partner with Insurance Providers to Cover FDA-Authorized At-Home COVID-19 Test

Dec 07, 2020 | Collaboration

47. INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19

Dec 07, 2020 | Clinical Trial

48. NeuroRx and Relief Therapeutics Meet 165 Patient Enrollment Target in Phase 2b/3 Trial of RLF-100 for Critical COVID-19 with Respiratory Failure

Dec 07, 2020 | Clinical Trial

49. Hematologists Play Vital Role in Advancing COVID-19 Research, Potential Treatments

Dec 05, 2020 | Clinical Trial

50. New CRISPR-Based Test for COVID-19 Uses a Smartphone Camera

Dec 04, 2020 | Regulatory

51. Lilly and UnitedHealth Group Partner on Pragmatic Study of Neutralizing Antibody Bamlanivimab (LY-CoV555) for COVID-19

Dec 04, 2020 | Collaboration

52. Senhwa Announces the First Patient Enrolled in an Investigator Initiated Trial Of Silmitasertib as a Treatment for COVID-19

Dec 03, 2020 | Clinical Trial

53. Ixlayer and CIC Health Partner to Make COVID-19 Tests More Accessible to School Districts and Universities

Dec 03, 2020 | Collaboration

54. Drawbridge Health Partners with University of Cambridge Researchers for Use of OneDraw Blood Collection Device in COVID-19 and Other Clinical Studies

Dec 03, 2020 | Collaboration

55. Made-in-Canada COVID Testing Now Available: LuminUltra Receives Health Canada Authorization for Rapid, Portable COVID-19 qPCR Testing Solutions

Dec 03, 2020 | Regulatory

56. INOVIO Expands Global Manufacturing Consortium For Its COVID-19 Vaccine Candidate INO-4800 With Addition of Kaneka Eurogentec S.A.

Dec 03, 2020 | Regulatory

57. Octapharma USA Presents Results of Investigational Use of Octagam 10% for Severe COVID-19 Patients at ASH Annual Meeting

Dec 02, 2020 | Clinical Trial

58. Ampio’s Phase I Study For Inhaled Ampion Advances To Completing Enrollment Of COVID-19 Patients With Respiratory Distress

Dec 02, 2020 | Clinical Trial

59. European Based Rapid PCR-COVID19 Home-Test Company Selfdiagnostics is toSubmit Request for Authorisation

Dec 02, 2020 | Regulatory

60. Celularity Announces Positive DMC Safety Review and Continuation of its Phase I/II CYNK-001-COVID-19 (CYNKCOVID) Study

Dec 01, 2020 | Clinical Trial

61. World’s Leading Life Science Companies Now Enrolling COMMUNITY, A Global, Platform Trial For Hospitalized Patients With COVID-19

Nov 30, 2020 | Clinical Trial

62. Harvard’s Wyss Institute Licenses its eRapid Technology to The iQ Group Global to Accelerate the Development of COVID-19 Diagnostics

Nov 30, 2020 | Regulatory

63. LuminUltra Expands Testing Capacity Including Range of COVID-19 Offerings with Acquisition of Source Molecular Corporation

Nov 30, 2020 | Collaboration

64. Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization

Nov 30, 2020 | Clinical Trial

Related Post:-  Insights+: COVID-19 Healthcare News Monthly Updates – November 2020

The post Insights+: COVID-19 Healthcare News Monthly Updates – December 2020 first appeared on PharmaShots.

Platform study designed to rapidly screen potential Covid-19 drugs enrolls first patients

Three of the companies making drugs used in the Phase II I-SPY COVID-19 study – Amgen, AbbVie and Takeda – announced the patient enrollments Monday. The study, which will enroll up to 1,500 critically ill patients, could test around 10 drugs.